Gabapentin-induced Facial Myoclonus in the Setting of Acute on Chronic Kidney Disease
- PMID: 31363439
- PMCID: PMC6663113
- DOI: 10.7759/cureus.4758
Gabapentin-induced Facial Myoclonus in the Setting of Acute on Chronic Kidney Disease
Abstract
An 82-year-old male with chronic kidney disease presented to the emergency department with sudden onset of left sided facial myoclonus. Myoclonus is a rare, but known side effect of gabapentin; however, there does not appear to be documented cases of gabapentin-induced facial myoclonus described in the emergency medicine literature. This case discusses the emergency department evaluation and inpatient treatment of gabapentin-induced facial myoclonus in the setting of acute on chronic kidney disease. Though rare, side effects of gabapentin should remain on a broad differential diagnosis in patients taking the medication who present with myoclonus, especially in the setting of chronic kidney disease.
Keywords: gabapentin; myoclonus.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Gabapentin and pregabalin for pain — is increased prescribing a cause for concern? Goodman CW, Brett AS. N Engl J Med. 2017:411–414. - PubMed
-
- Gabapentin-induced myoclonus: a case report. Ozmenoglu M, Gazioglu S, Cakmak V, et al. J Neurol Sci. 2015;357:282–283. - PubMed
-
- Gabapentin-induced myoclonus in end-stage renal disease. Zhang C, Glenn DG, Bell WL, et al. Epilepsia. 2005;46:156–158. - PubMed
Publication types
LinkOut - more resources
Full Text Sources